NO20044555L - Kombinasjonsprodukt omfattende en antikoagulant og anti-arrytmiske oksabispidener - Google Patents

Kombinasjonsprodukt omfattende en antikoagulant og anti-arrytmiske oksabispidener

Info

Publication number
NO20044555L
NO20044555L NO20044555A NO20044555A NO20044555L NO 20044555 L NO20044555 L NO 20044555L NO 20044555 A NO20044555 A NO 20044555A NO 20044555 A NO20044555 A NO 20044555A NO 20044555 L NO20044555 L NO 20044555L
Authority
NO
Norway
Prior art keywords
anticoagulant
combination product
oxabispidides
antiarrhythmic
compound
Prior art date
Application number
NO20044555A
Other languages
English (en)
Inventor
Elisabeth Svernhage
Ann-Charlotte Roth-Rosendahl
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20044555L publication Critical patent/NO20044555L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines having two or more nitrogen atoms in the same ring, e.g. oxadiazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Det er tilveiebrakt et kombinasjonsprodukt omfattende: en antikoagulant; og (1) en forbindelse definert i krav 1 ifølge WO 01128992 eller (2) en forbindelse ifølge krav 34 ifølge WO 01128992 eller (3) forbindelse A eller B eller C eller D (eller farmasøytisk akseptable salter derav) for anvendelse ved behandling av arytmi eller en koagulasjonskontrollert komplikasjon ved dette. Forbindelser ifølge WO 01128992 er definert med formel (I). Forbindelse A, B, C og D er derivater av 9-oksa-3,7-diazabicyklo[3.3.1.]non-3-an.
NO20044555A 2002-05-06 2004-10-22 Kombinasjonsprodukt omfattende en antikoagulant og anti-arrytmiske oksabispidener NO20044555L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0201374A SE0201374D0 (sv) 2002-05-06 2002-05-06 Pharmaceutical combination
PCT/SE2003/000719 WO2003092720A1 (en) 2002-05-06 2003-05-05 A combination product comprising an anti-coagulant and anti-arrhythmic oxabispidenes

Publications (1)

Publication Number Publication Date
NO20044555L true NO20044555L (no) 2004-11-16

Family

ID=20287789

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044555A NO20044555L (no) 2002-05-06 2004-10-22 Kombinasjonsprodukt omfattende en antikoagulant og anti-arrytmiske oksabispidener

Country Status (19)

Country Link
US (1) US20050119259A1 (no)
EP (1) EP1503783A1 (no)
JP (1) JP2005529140A (no)
KR (1) KR20040104692A (no)
CN (1) CN1652812A (no)
AR (1) AR039883A1 (no)
AU (1) AU2003230517A1 (no)
BR (1) BR0309336A (no)
CA (1) CA2485086A1 (no)
IL (1) IL164939A0 (no)
IS (1) IS7536A (no)
MX (1) MXPA04010717A (no)
NO (1) NO20044555L (no)
PL (1) PL372526A1 (no)
RU (1) RU2004129729A (no)
SE (1) SE0201374D0 (no)
TW (1) TW200307549A (no)
WO (1) WO2003092720A1 (no)
ZA (1) ZA200408618B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20042068A1 (it) * 2004-10-29 2005-01-29 Opocrin Spa Nuovo uso di eparine a bassissimo peso molecolare
WO2006137772A1 (en) * 2005-06-20 2006-12-28 Astrazeneca Ab New physical form of n,n´- disubstituted oxabispidines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU178398B (en) * 1979-06-12 1982-04-28 Gyogyszerkutato Intezet Process for producing new agmatine derivatives of activity against haemagglutination
SE9903759D0 (sv) * 1999-10-18 1999-10-18 Astra Ab Pharmaceutically active compounds
US6462021B1 (en) * 2000-11-06 2002-10-08 Astrazeneca Ab Use of low molecular weight thrombin inhibitor

Also Published As

Publication number Publication date
CA2485086A1 (en) 2003-11-13
AR039883A1 (es) 2005-03-09
IL164939A0 (en) 2005-12-18
WO2003092720A8 (en) 2005-03-10
MXPA04010717A (es) 2005-03-07
JP2005529140A (ja) 2005-09-29
BR0309336A (pt) 2005-03-08
PL372526A1 (en) 2005-07-25
US20050119259A1 (en) 2005-06-02
SE0201374D0 (sv) 2002-05-06
ZA200408618B (en) 2006-06-28
CN1652812A (zh) 2005-08-10
IS7536A (is) 2004-11-18
KR20040104692A (ko) 2004-12-10
AU2003230517A1 (en) 2003-11-17
EP1503783A1 (en) 2005-02-09
WO2003092720A1 (en) 2003-11-13
RU2004129729A (ru) 2005-07-10
TW200307549A (en) 2003-12-16

Similar Documents

Publication Publication Date Title
NO20044974L (no) Imidazo [1,2-a]pyrazin-8-ylaminer, fremgangsmater for fremstilling og anvendelse derav
UA74346C2 (uk) Похідні амінодикарбонових кислот, їх застосування та лікарський засіб
NO20054852L (no) GFAT inhibitorer
NO20042161L (no) Inhibitorer av 11-beta-hydroksysteroid dehydrogenase type 1
EP0866059A4 (en) NOVEL HETEROCYCLIC DERIVATIVES AND THEIR MEDICINAL USE
NO20065904L (no) Terapeutiske forbindelser
NO20041041L (no) Fenetanolaminderivater for behandling av respiratoriske sykdommer
NO20070576L (no) Nye hydantionderivater for behandling av obstruktive luftveissykdommer.
NO20044501L (no) [1,4] diazenino [6,7,1-IJ] kinolin-derivater som antipsykotis og antifedme-midler
IL158975A0 (en) 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors
JO2353B1 (en) New derivatives of mixed-ring fluoroglycosides and drugs containing these compounds and their use
DE60315674D1 (de) Neue imidazopyridine und ihre verwendung
WO2001027111A3 (de) Bicyclische imidazo-3-yl-aminderivate
WO2003013484A3 (en) N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents
GEP20043324B (en) Purine Derivatives
AU2001293233A1 (en) Aza heterocyclic derivatives and their therapeutic use
NO20092033L (no) Nye forbindelser
EP1400529A4 (en) GLUCOPYRANOSYLOXYPYRAZOLE DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND MEDICINAL AND INTERMEDIARY USE THEREOF
NO944911L (no) Ikke-peptid-takykininreseptorantagonister
DE60305514D1 (de) Neue verwendung von benzothiazolderivaten
NO20060147L (no) Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav
WO2003008365A3 (en) Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
NO20060146L (no) Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav
NO20052182L (no) Nye forbindelser
MXPA02006249A (es) Nuevos derivados de azabiciclooctano, utiles en el tratamiento de arritmias cardiacas.